24 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 32176647 | Oxidized Products of Omega-6 and Omega-3 Long Chain Fatty Acids Are Associated with Increased White Matter Hyperintensity and Poorer Executive Function Performance in a Cohort of Cognitively Normal Hypertensive Older Adults. | 2020 | 3 |
2 | 32182938 | Assessment of the Effect of Sorafenib on Omega-6 and Omega-3 Epoxyeicosanoid Formation in Patients with Hepatocellular Carcinoma. | 2020 Mar 9 | 2 |
3 | 32192153 | Soluble Epoxide Hydrolase 2 Expression Is Elevated in Obese Humans and Decreased by Physical Activity. | 2020 Mar 17 | 1 |
4 | 29960002 | Expression of cytochrome P450 epoxygenases and soluble epoxide hydrolase is regulated by hypolipidemic drugs in dose-dependent manner. | 2018 Sep 15 | 2 |
5 | 30031209 | Neuroprotective effects of epoxyeicosatrienoic acids. | 2018 Sep | 2 |
6 | 25824304 | Dysregulation of soluble epoxide hydrolase and lipidomic profiles in anorexia nervosa. | 2016 Apr | 4 |
7 | 26621325 | Soluble epoxide hydrolase: A potential target for metabolic diseases. | 2016 May | 2 |
8 | 27079253 | 11,12-Epoxyecosatrienoic acids mitigate endothelial dysfunction associated with estrogen loss and aging: Role of membrane depolarization. | 2016 May | 2 |
9 | 25330284 | Whatever happened to the epoxyeicosatrienoic Acid-like endothelium-derived hyperpolarizing factor? The identification of novel classes of lipid mediators and their role in vascular homeostasis. | 2015 May 10 | 2 |
10 | 26453326 | Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration. | 2015 Dec 1 | 2 |
11 | 25173047 | Arg287Gln variant of EPHX2 and epoxyeicosatrienoic acids are associated with insulin sensitivity in humans. | 2014 Oct | 1 |
12 | 22303912 | Soluble epoxide hydrolase inhibitors and cardiovascular diseases. | 2013 Jan | 2 |
13 | 23701967 | Soluble epoxide hydrolase: gene structure, expression and deletion. | 2013 Sep 10 | 2 |
14 | 22116511 | Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease. | 2012 Feb 1 | 2 |
15 | 22298653 | Epoxides and soluble epoxide hydrolase in cardiovascular physiology. | 2012 Jan | 2 |
16 | 21825980 | Cytochrome P450-dependent eicosanoid production and crosstalk. | 2011 Oct | 1 |
17 | 20339956 | Development of a high throughput cell-based assay for soluble epoxide hydrolase using BacMam technology. | 2010 Jul | 1 |
18 | 20425256 | Soluble epoxide hydrolase in atherosclerosis. | 2010 May | 2 |
19 | 20531214 | Targeting epoxides for organ damage in hypertension. | 2010 Oct | 2 |
20 | 19794443 | Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. | 2009 Oct | 2 |
21 | 16961727 | Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors. | 2006 Summer | 3 |
22 | 18221075 | Soluble epoxide hydrolase: a novel target for the treatment of hypertension. | 2006 Jan | 2 |
23 | 10775319 | Toxicity of epoxy fatty acids and related compounds to cells expressing human soluble epoxide hydrolase. | 2000 Apr | 1 |
24 | 10775430 | Metabolism of monoepoxides of methyl linoleate: bioactivation and detoxification. | 2000 Apr 15 | 2 |